← Leaderboards
Matthew Spitzer
Stanford University
$5,541,822
Attributed
$6,179,116
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,179,116 · 5
By mechanism
R01$3,757,668 · 2
DP5$1,900,275 · 1
R21$448,937 · 1
F31$72,236 · 1
Top collaborators
- Kara Lynn Davis2 shared
- Joy Y Wu2 shared
- Mekhail Anwar1 shared
Most similar at Stanford University
Same institution · by research overlap
- Robert Michael Angelo$7,860,542
- Garry P Nolan$53,568,535
- Marlene Rabinovitch$40,032,014
- Christina N Curtis$16,294,717
- William H Robinson$16,848,609
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsImmunotherapyCellsImmune ResponseNeoplastic CellTumorImmune SystemCytokineImmunePersonsImmunologicsSignal TransductionT-LymphocyteResponseComplexCancer ImmunotherapyMouse ModelMeasurementTumor ImmunityMolecularResolutionNeoplasm MetastasisExhibitsBehavior
Grant awards (15)
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging$738,039
R01 · FY2025 · DE · contact PI
Early identification of immunotherapy resistance through integrated multiparameter imaging$676,006
R01 · FY2025 · CA
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging$723,279
R01 · FY2024 · DE · contact PI
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging$734,970
R01 · FY2023 · DE · contact PI
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging$135,964
R01 · FY2023 · DE · contact PI
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging$749,410
R01 · FY2022 · DE · contact PI
Quantitatively modeling immune responses to cancer$366,151
DP5 · FY2020 · OD · contact PI
Quantitatively modeling immune responses to cancer$377,144
DP5 · FY2019 · OD · contact PI
Quantitatively modeling immune responses to cancer$382,697
DP5 · FY2018 · OD · contact PI
Single-cell High-dimensional Characterization of the Bone Marrow Microenvironment in Health and Disease$197,763
R21 · FY2018 · AG
Quantitatively modeling immune responses to cancer$392,658
DP5 · FY2017 · OD · contact PI
Single-cell High-dimensional Characterization of the Bone Marrow Microenvironment in Health and Disease$251,174
R21 · FY2017 · AG
Quantitatively modeling immune responses to cancer$381,625
DP5 · FY2016 · OD · contact PI
Revealing the tumor-immune network by mass cytometry$29,560
F31 · FY2015 · CA · contact PI
Revealing the tumor-immune network by mass cytometry$42,676
F31 · FY2014 · CA · contact PI